SCHEMBL19954603

SCHEMBL19954603

CC(C)(C)c1cc(C(F)(F)F)nn1C1CCN(CCO)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.43
IRAK4 Q9NWZ3 3/20 0.39
NR3C1 P04150 1/20 0.38
MAPK1 P28482 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
THRB P10828 1/20 0.36
TSHR P16473 1/20 0.36
KHK P50053 1/20 0.35
TGFBR1 P36897 1/20 0.34
SLC18A3 Q16572 1/20 0.34
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34
HSD17B10 Q99714 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
DRD2 P14416 4/20 0.34
KCNH2 Q12809 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16805973 0.85 NR3C1 (0.41) TRPV4IRAK4NR3C1MAPK1ALDH1A1
SCHEMBL19953971 0.83 TRPV4 (0.41) TRPV4NR3C1MAPK1ALDH1A1HPGD
SCHEMBL22560184 0.82 TGFBR1 (0.38) TRPV4LMNAGAATGFBR1NR3C2
SCHEMBL19954664 0.81 MAPK1 (0.39) TRPV4IRAK4NR3C1MAPK1ALDH1A1
SCHEMBL24813393 0.81 MAPK13 (0.33) TRPV4DRD2DRD4DRD3
SCHEMBL19954636 0.80 NR3C2 (0.39) ALDH1A1GAATGFBR1HSD17B10KCNH2
SCHEMBL25745883 0.79 DRD2 (0.39) ALDH1A1DRD2HTR1AHTR2ADRD3
SCHEMBL19954641 0.78 NR3C1 (0.35) NR3C1TGFBR1NR3C2
SCHEMBL18164008 0.78 GAA (0.38) TRPV4IRAK4NR3C1MAPK1LMNA
SCHEMBL19954631 0.76 TGFBR1 (0.43) IRAK4TGFBR1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914706-B2 N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-13 US disclosed